Atlas Trials

Oyster Point Pharma, Inc.

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Oyster Point Pharma, Inc.

RecordFirmDate
A Study Evaluating the Safety of the Nasal Pump (NCT06329687)Oyster Point Pharma, Inc.2024-02-21
Phase 4 Study Evaluating the Safety of the Nasal Guide With Tyrvaya (NCT05918406)Oyster Point Pharma, Inc.2023-06-14
Phase 2 Clinical Trial to Evaluate OC-01 Nasal Spray in Subjects With Neurotrophic Keratopathy (NCT04957758)Oyster Point Pharma, Inc.2021-06-17
Evaluating Relative Bioavailability of OC-01 (Varenicline) Nasal Spray as Compared to Orally Administered Varenicline (NCT04072146)Oyster Point Pharma, Inc.2019-08-26
Evaluation of the Efficacy and Safety of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease (NCT04036292)Oyster Point Pharma, Inc.2019-07-23
Clinical Trial to Evaluate the Chronic Efficacy of OC-01 Nasal Spray on Signs of Dry Eye Disease (The MYSTIC Study) (NCT03873246)Oyster Point Pharma, Inc.2019-02-18
Efficacy of OC-01 Nasal Spray on Goblet Cell and Meibomian Gland Stimulation (NCT03688802)Oyster Point Pharma, Inc.2018-09-25
Evaluation of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease (NCT03636061)Oyster Point Pharma, Inc.2018-08-15
Evaluation of the Long Term Follow up of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease (NCT03920215)Oyster Point Pharma, Inc.2018-08-15
Evaluation of the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (the RAINIER Study) (NCT03633461)Oyster Point Pharma, Inc.2018-08-14
Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The PEARL Study) (NCT03452397)Oyster Point Pharma, Inc.2018-02-27

Track Oyster Point Pharma, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.